Press Release Vanta Announces Engagement of Independent Trading Group for Market-Making Services to Support Strategic Capital Markets Initiatives Aug 27
Press Release Vanta Announces Closing of First Tranche of Private Placement and Board of Directors Update Aug 21
Press Release Vanta Commends U.S. FDA Advisory Committee Vote Recommending Inclusion of Six Peptide Substances on FDA’s 503A Bulks List, Including BPC-157, TB-500 and MOTS-c Jul 28